Reducing unnecessary medications for dementia patients in assisted living
Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living
NA · Vanderbilt University · NCT05956665
This study is testing a way to safely reduce unnecessary medications for people with dementia living in assisted living facilities to see if it improves their quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Vanderbilt University (other) |
| Locations | 2 sites (Nashville, Tennessee and 1 other locations) |
| Trial ID | NCT05956665 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to evaluate a deprescribing intervention for residents with dementia living in assisted living facilities. The intervention focuses on safely reducing the number of unnecessary or potentially harmful medications based on clinical criteria and the preferences of residents or their surrogates. Participants will undergo a comprehensive medication review, and recommendations will be made to stop or reduce doses of certain medications. The study will assess the total number of medications deprescribed and gather quality of life reports from residents and their surrogates at enrollment and after 90 days.
Who should consider this trial
Good fit: Ideal candidates are residents of assisted living facilities aged 65 and older with a diagnosis of dementia who are taking multiple medications.
Not a fit: Patients who are not residents of assisted living facilities or do not have a dementia diagnosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance the quality of life for dementia patients by minimizing medication burden.
How similar studies have performed: Previous studies, such as the Shed-MEDS trial, have shown success in reducing medication burden in older adults, indicating potential for this approach in dementia care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Resident of assisted living facility * Speaks English (due to interview-based assessments) * Diagnosis of dementia * Taking a total of 5 medications or at least one potentially inappropriate medication (defined by the Beers criteria, STOPP criteria, and the Rationalization of home medication by an Adjusted STOPP in older Patients \[RASP\]) * Able self-consent or has a proxy (surrogate) Exclusion Criteria: - None
Where this trial is running
Nashville, Tennessee and 1 other locations
- Abe's Garden Community — Nashville, Tennessee, United States (RECRUITING)
- NHC At The Trace — Nashville, Tennessee, United States (RECRUITING)
Study contacts
- Study coordinator: Jennifer Kim, DNP
- Email: jennifer.kim@vanderbilt.edu
- Phone: 6159360739
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Polypharmacy, Dementia, Quality of Life, Deprescribing